XML 26 R13.htm IDEA: XBRL DOCUMENT v3.20.1

Commitments and Contingencies (Tables)

6 Months Ended

Mar. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Schedule of exercisable share purchase warrants outstanding

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

			Number of Shares				Weighted Average Exercise Price ($)
	Balance, September 30, 2018			678,379				2.87
	Exercised			(8,750	)			1.13
	Expired			(319,629	)			1.46
	Balance, September 30, 2019			350,000				4.19
	Granted			150,000				3.17
	Balance, March 31, 2020			500,000				3.88

Schedule of share purchase warrants outstanding

At March 31, 2020, the Company had share purchase warrants outstanding as follows:

Number				Exercise Price				Expiry Date
	350,000			$	4.19			June 30, 2021
	150,000			$	3.17			May 6, 2024
	500,000

Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

			Number of Shares				Weighted Average Exercise Price ($)				Weighted Average Grant Date Fair Value ($)				Aggregate intrinsic value ($)
	Outstanding, September 30, 2018			6,506,917				3.83								2,353,088
	Granted			2,265,399				2.79				2.27
	Forfeited			(309,383	)			3.25
	Outstanding, September 30, 2019			8,462,933				3.58								4,115,032
	Granted			1,525,000				2.86				2.17
	Forfeited			(1,667	)			2.64
	Outstanding, March 31, 2020			9,986,266				3.47								4,517,080
	Exercisable, March 31, 2020			6,925,642				3.70								3,815,680

Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s interim condensed consolidated statements of operations as follows:

			Three months ended March 31,								Six months ended March 31,
			2020				2019				2020				2019
	General and administrative		$	810,309			$	950,999			$	1,291,410			$	2,006,587
	Research and development			890,444				942,153				1,673,767				1,953,552
	Total share based compensation		$	1,700,753			$	1,893,152			$	2,965,177			$	3,960,139

Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

		2020				2019
Risk-free interest rate			1.68	%			2.91	%
Expected life of options (years)			5.44				5.59
Annualized volatility			97.61	%			105.96	%
Dividend rate			0.00	%			0.00	%

X

- References

No definition available.

+ Details

Name:	avxl_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock
Namespace Prefix:	avxl_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in stock options.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration